Literature DB >> 15727934

The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene transfer vector to neural progenitors in the murine brain.

Colleen S Stein1, Inês Martins, Beverly L Davidson.   

Abstract

Feline immunodeficiency virus (FIV)-based lentiviral vectors can be targeted to restricted cell types by pseudotyping with envelopes from other viruses. An FIV vector expressing bacterial beta-galactosidase (beta-gal) and pseudotyped with lymphocytic choriomeningitis virus (LCMV) envelope glycoprotein was injected into postnatal mouse brain striatum to determine neural cell-type transduction. After 3 or 7.5 weeks, the beta-gal-expressing cells included astrocytes in the striatum and in the subventricular zone (SVZ), neuroblasts along the rostral migratory stream, and neurons in the olfactory bulb. This pattern was suggestive of transduction of neural stem cells/progenitors that reside in the SVZ and continually generate olfactory bulb neurons. To test for transduction of SVZ type B astrocyte/stem cells, LCMV-pseudotyped FIV encoding Cre recombinase driven by an astrocyte-specific promoter was injected into the striatum of ROSA26 Cre reporter mice. beta-Gal expression in these mice depends on Cre recombinase-mediated DNA recombination. beta-Gal-expressing neuroblasts and neurons were detected in the rostral migratory stream and olfactory bulb, respectively, indicating that these cells derived from an astrocytic-type stem cell. Thus, LCMV (WE54)-pseudotyped FIV provides a novel vector for transducing neural stem cells/progenitors in vivo and may prove valuable as a gene transfer vector for therapy of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727934     DOI: 10.1016/j.ymthe.2004.11.008

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  17 in total

1.  Optimization of feline immunodeficiency virus vectors for RNA interference.

Authors:  Scott Q Harper; Patrick D Staber; Christine R Beck; Sarah K Fineberg; Colleen Stein; Dalyz Ochoa; Beverly L Davidson
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

Review 3.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

Review 4.  Recent advances in RNA interference therapeutics for CNS diseases.

Authors:  Pavitra S Ramachandran; Megan S Keiser; Beverly L Davidson
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

5.  Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.

Authors:  Alexander Muik; Inna Kneiske; Marina Werbizki; Doris Wilflingseder; Tsanan Giroglou; Oliver Ebert; Anna Kraft; Ursula Dietrich; Gert Zimmer; Stefan Momma; Dorothee von Laer
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain.

Authors:  Annalisa Buffo; Inmaculada Rite; Pratibha Tripathi; Alexandra Lepier; Dilek Colak; Ana-Paula Horn; Tetsuji Mori; Magdalena Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

7.  Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type composition.

Authors:  Elise B Peterson; Michael A Mastrangelo; Howard J Federoff; William J Bowers
Journal:  Mol Ther       Date:  2007-07-24       Impact factor: 11.454

8.  Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism.

Authors:  Douglas E Dylla; Litao Xie; Daniel E Michele; Stefan Kunz; Paul B McCray
Journal:  Genet Vaccines Ther       Date:  2011-04-08

9.  Lentivirus-mediated transgene delivery to the hippocampus reveals sub-field specific differences in expression.

Authors:  Lenneke W A van Hooijdonk; Muhammad Ichwan; Thomas F Dijkmans; Theo G Schouten; Marijke W A de Backer; Roger A H Adan; Fons J Verbeek; Erno Vreugdenhil; Carlos P Fitzsimons
Journal:  BMC Neurosci       Date:  2009-01-13       Impact factor: 3.288

10.  Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification.

Authors:  Henning Lauterbach; Phi Truong; Dorian B McGavern
Journal:  Virol J       Date:  2007-06-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.